Spectrum Health Ventures

SpendMend is a healthcare organization that focuses on helping healthcare entities identify and mitigate financial leakage. The company provides spend visibility and audit recovery services aimed at detecting payment errors and contract non-compliance within clients' operating expenses. By utilizing a technology-driven platform, SpendMend enables healthcare organizations to generate cost savings and enhance their cost cycle management. This approach not only helps clients shrink financial losses but also prevents future occurrences, effectively addressing control gaps that can lead to over-payments.

KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

Professional Credentials Exchange, LLC operates a blockchain-based platform designed to streamline the verification of professional credentials, primarily within the U.S. healthcare sector. The company's marketplace, ProCredEx, allows healthcare organizations to share, exchange, and monetize verified credential data efficiently. By connecting vetted members, the platform facilitates the buying and selling of professional credentials, thereby accelerating the deployment of clinicians in healthcare settings. This digital marketplace addresses the historical challenges of cost, complexity, and delays associated with practitioner credentialing by providing a secure and reliable infrastructure for credential verification. Founded in 2018 and based in Tampa, Florida, Professional Credentials Exchange focuses on creating a network that enhances the flow of credential information among industry stakeholders, rather than developing a traditional credentialing system.

VyncaCare provides palliative care, advanced care planning, and enhanced care management services.

Lumere, Inc. is a Chicago-based organization that offers a cloud-based platform designed to assist hospitals and healthcare providers in reducing clinical variation and minimizing costs related to medical devices and pharmaceuticals. The company provides a suite of tools, including Product Introduction Management, which refines the device vetting process using clinical evidence and industry best practices. Its Category Optimization service integrates clinical insights and market intelligence to identify savings opportunities within health systems. Additionally, Lumere's Variation Management analyzes procedural utilization data to evaluate how medical devices are used by physicians, while its Utilization Management combines relevant clinical information with prescriber patterns to optimize drug spending. The organization also offers physician advisory services to foster collaboration between clinicians and hospital leadership. Lumere was incorporated in 2012 and operates as a subsidiary of Global Healthcare Exchange, LLC.

ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly targeting conditions related to the heart, liver, and neurodegeneration. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology that allows for the differentiation of cells into any type found in the body. This technology is employed to test drug efficacy, screen for medication toxicity, and create personalized treatment pathways. The company offers a range of products, including LifeProfiles, which provides genetic insights related to fitness, metabolism, and exercise recovery; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.

ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly targeting conditions related to the heart, liver, and neurodegeneration. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology that allows for the differentiation of cells into any type found in the body. This technology is employed to test drug efficacy, screen for medication toxicity, and create personalized treatment pathways. The company offers a range of products, including LifeProfiles, which provides genetic insights related to fitness, metabolism, and exercise recovery; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.